1 / 43

IBD – ” top – to – toe ” Aida Kapic Lunder, MD, Research Fellow

IBD – ” top – to – toe ” Aida Kapic Lunder, MD, Research Fellow. *Kaplan and Ng. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 2017. “ IBD as a systemic disease with a predilection for the gut. ”. Adapted from Baumgart and Sandborn.

duncanjoseph
Télécharger la présentation

IBD – ” top – to – toe ” Aida Kapic Lunder, MD, Research Fellow

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IBD –”top – to – toe” Aida Kapic Lunder, MD, Research Fellow *Kaplan and Ng. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 2017

  2. “IBD as a systemic disease with a predilection for the gut.” Human touch and empathy – with professional skill Adapted from Baumgart and Sandborn

  3. Prevalence of extra-intestinal manifestations (EIM) (6-38%) More common in patients with CD and women

  4. Extra-intestinal manifestations (EIM) Immune mediated Non immune mediated Osteoporosis Cholelithiasis Nephrolithiasis Anemia Urogenital affection Central nervous system affection Cardiovascular affection Pulmonary affection • Arthropathies • Sclerosing cholangitis • Skin disorders • Eye disorders

  5. IBD-related spondyloarthropathy (“gut-synovial axis”) – Most common! Peripheral (5-20%) Axial Inflammatory back pain Spondyloarthritis (16-46%) Ankylosing spondylitis (1-16%) Imaging important! • Symmetric non-deforming arthritis • Usually self-limiting • Large weight-bearing joints • Non-spesific findings: enthesitis, joint effusion, periarticular osteopenia, dactylitis

  6. Spondyloarthritis – ASAS MRI working group(Assessment in SpondyloArthritis International Society) Active inflammatory lesions Structural damage lesions Subchondral sclerosis Erosions Fat deposition Ankylosis (bone bridging) • Bone marrow edema/osteitis • Synovitis • Enthesitis • Capsulitis Lambert et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Annals of the rheumatic diseases. 2016.

  7. Active sacroiliitis

  8. Structural damage lesions

  9. CT lesions Prakash D et al. Seronegative spondyloarthropathy-related sacroiliitis: CT, MRI features and differentials. Indian J Radiol Imaging 2014;24:271-8

  10. Complete ankylosis of both sacroiliac joints

  11. Sacroiliitis, MR enterography T2 FS • 57 y male, CD and PSC Ossum et al. Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study. Journal of Crohn's & colitis. 2017.

  12. Ankylosing spondylitis (1-16%) • Diagnosed when both the • clinical criteria (back pain, stiffness and/or limitation of motion) and • the imaging criteria for sacroiliitis (grade 2 or more bilaterally or grade 3-4 unilaterally) • are met.

  13. Primary sclerosing cholangitis (PSC) – most severe! • 70-80% PSC patients have IBD • 1.4-7.5% IBD patients have PSC

  14. “A patchwork of different phenotypes” The PSC Institute, Rikshospitalet, Norway

  15. Diagnostic work-up • Tricky diagnostics (symptoms? alkaline phosphatase levels?) • MR cholangiography (sens 80 %, spes 87 %) • ERCP • Biopsy – Small duct PSC 5-10 % • Complications? risk of colorectal cancer (x 5) risk of cholangiocarcinoma (x160-1500) Follow-up!

  16. PSC on MRC Strictures Dilatations Mural irregularities Beading Lunder et al. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. Gastroenterology. 2016;151(4):660-9.e4.

  17. CCA – 5-15 % life time incidence in patients with PSC! • Overlapping imaging findings • Look for: • Focal thickening • Focal Biliary dilatation • Capsular retractions • Portal vein invasion • Fibrous tissue in CCA  delayed enhancement

  18. PSC with hilar cholangiocarcinoma (Klatskin tumor) Hussain S. M. et al (2015). Liver MRI: Correlation with other imaging modalities and histopathology, second edition. Springer International Publishing.

  19. PSC with hilar cholangiocarcinoma (Klatskin tumor)

  20. Immune-mediated conditions: Skin • Enterocutaneous fistulas (30%) • Aphthous stomatitis (1-10%) • Erythema nodosum (2-15%) • Pyoderma gangrenosum (0.5–2%)

  21. Immune-mediated conditions: Eye • Uveitis (0.5-3.0%) • Episcleritis (0.2%)

  22. Non immune mediated manifestations

  23. Enterourinary fistulas (2-3.5%, CD)

  24. Enterogenital fistulas Olpin et al. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease, radiographics.rsna.org

  25. Obstructive nephropathy (1.9-6% in CD) Olpin et al. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease, radiographics.rsna.org

  26. Gall bladder stones (13-34 % in CD)

  27.  NECT Kidney stones (12% in CD) Brisbane et al. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 November.

  28. Hepatic steatosis (≈35%) • Due to chronic malnutrition, protein loss, corticosteroid therapy? Lee SS et al . Nonalcoholic fatty liver disease. World J Gastroenterol 2014 June 21; 20(23): 7392-7402

  29. Coagulopathy  venous tromboembolism Surgical intervention Exacerbation

  30. Case courtesy of Dr Bruno Di Muzio, Radiopaedia.org, rID: 44167 24-year old male with known CD, abdominal distention and vomiting. Treated with partial right colon and distal ileum resection 1,5 year ago.

  31. Portal vein thrombosis

  32. Osteoporosis (15%) • Etiology: inflammatory-mediated bone resorption, malabsorption, poor diet, corticosteroids, reduced physical activity • Underdiagnosed... L1- values ≤135 HU: Sens 76%, Spes 75% for osteoporosis

  33. Neurological manifestations • Rare, secondary? Drug-induced?

  34. 40-year old female with CD (at 20 y follow-up)

  35. Multiple sclerosis – remitting relapsing type Treated with ileocoecal resection in 2013 Under immunosuppressive treatment  quiescent CD and MS today

  36. Which EIMs are attributable to IBD? To what extent? • 56,097 IBD patients were matched to 280,382 non-IBD controls • Associated with IBD: PSC (OR = 188.25), pyoderma gangrenosum (OR = 29.24), ankylosing spondylitis (OR = 7.07), erythema nodosum (OR = 5.95), uveitis (OR = 2.81), sacroiliitis (OR = 2.79), non-rheumatoid inflammatory arthritides (OR = 2.66)

  37. Cardiovascular manifestations of IBD

  38. Aims of diagnostic imaging • Assess and characterize: • Disease extent • Disease activity Establish the diagnosis of IBD • Assess • Complications • Systemic manifestations of IBD • Characterize CD behavior: • Inflammatory • Fibrostenosing • Fistulizing Suggest additional examinations

  39. Summary • IBD is a systemic disease with increasing incidence rates • Radiologic imaging is indispensable in modern care of IBD patients • CT and MR techniques offer excellent imaging of intra- and extra-luminal disease • Get used to reporting complications and other manifestations of IBD! Avoid “Satisfaction of search”!

  40. References • Card TR, Langan SM, Chu TP. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported. Digestive diseases and sciences. 2016;61(9):2619-26. • Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's & colitis. 2016;10(3):239-54. • Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152(2):313-21.e2. • Baumgart DC, Sandborn WJ. Crohn's disease. Lancet (London, England). 2012;380(9853):1590-605. • Olpin et al. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease, radiographics.rsna.org • Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic Screening for Osteoporosis Using Abdominal Computed Tomography Scans Obtained for Other Indications. Ann Intern Med. 2013;158:588–595. doi: 10.7326/0003-4819-158-8-201304160-00003 • Brisbane et al. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 November.

  41. References • Ossum AM, Palm O, Lunder AK, Cvancarova M, Banitalebi H, Negard A, et al. Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study. Journal of Crohn's & colitis. 2017. • Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Annals of the rheumatic diseases. 2016. • Radiopaedia • Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, et al. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. Gastroenterology. 2016;151(4):660-9.e4. • Hussain, S. M. et al (2015). Liver MRI: Correlation with other imaging modalities and histopathology, second edition. Springer International Publishing. • Prakash D et al. Seronegative spondyloarthropathy-related sacroiliitis: CT, MRI features and differentials. Indian J Radiol Imaging 2014;24:271-8 • Lee SS et al . Nonalcoholic fatty liver disease. World J Gastroenterol 2014 June 21; 20(23): 7392-7402

  42. Thanks to the Abdominal Radiology Section!

  43. Thank you! Human touch and empathy – with professional skill

More Related